glp-1 gastric emptying anesthesia It’s not because the medication itself is dangerous during anesthesia…, it’s because of how it affects emptying, The practice around GLP-1’s and is ever changing, however. , Perioperative management of patients taking

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Center for Complementary and Integrative Health (NCCIH) both acknowledge the evidence base for GLP-1 receptor agonists in obesity medicine as part of the broader federal research and clinical guidance infrastructure

10.1111/j.1399-3054.2004.00424.x 125 PieterseC

Obesity tends to be categorized as a cosmetic issue in health insurance policies, he says

Just based on two high level metrics when it was removed from the shortage list (based on pharmacy supply calls and patients pick up rates here at Ro): Pharmacy Supply Calls: 38% of pharmacies have stock 15% do not have stock but expect to have it in the future 48% say its on back order and materially less supply than other Wegovy doses Patient pick up rates: 30-35% are able to find supply in 14 days 65-70% are able to find supply in 30 days If providers are using the FDAs list to determine what path to recommend for their patients, we need to ensure the FDA has as much information as possible to make that determination